Clinical Trials Logo

Filter by:
NCT ID: NCT05252156 Completed - Clinical trials for Sleep Apnea, Obstructive

eXciteOSA for Treatment of Moderate Obstructive Sleep Apnea

ELMO
Start date: March 21, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to assess the efficacy of the eXciteOSA device amongst a sample of patients with moderate OSA. The study is a multi-center, prospective, open-label, randomized, parallel-arm trial of eXciteOSA (administered at two doses) versus no-therapy for six weeks. Up to 120 participants will be enrolled, in order to randomized n=62.

NCT ID: NCT05252052 Completed - Contraception Clinical Trials

Contraception Perspectives in Adolescents in Haiti

Start date: March 22, 2021
Phase:
Study type: Observational

The overall goal of this study is to assess facilitators and barriers to contraception with a focus on long-acting reversible contraception (LARC) among adolescents and health care providers (HCPs) in rural Haiti. The investigator plans to accomplish the following objectives:

NCT ID: NCT05251909 Completed - Clinical trials for Eosinophilic Gastroenteritis

Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)

HUDSON GI
Start date: January 18, 2022
Phase: Phase 3
Study type: Interventional

This is a 3-part study. Part A is randomized, double-blinded, placebo-controlled and includes patients with eosinophilic gastritis and/or duodenal-only disease. After completing Part A, participants can continue to Part C - open-label benralizumab treatment period. Following the decision to close enrollment, patients in both Part A and Part C will be given the option to proceed to 6-months of open-label benralizumab treatment in Part D.

NCT ID: NCT05251844 Completed - Clinical trials for Unauthorized Data Access

The Effectiveness of Email Alerting on Reducing Employees' Unauthorized Access to Protected Health Information

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

To assess the effectiveness of email warnings on reducing repeated unauthorized access to Protected Health Information (PHI), a randomized trial was conducted in a large academic medical center to understand the effectiveness of email warning on reducing repeated unauthorized access to PHI.

NCT ID: NCT05251740 Completed - Clinical trials for Spina Bifida With Hydrocephalus

Impact of a Standing Program in a Child With Spina Bifida: A Case Report

Start date: May 6, 2021
Phase: N/A
Study type: Interventional

The purpose of this case study is to investigate a child with MMC who has significant knee and hip flexion contractures to answer the following research questions: 1) Is a home standing program effective in reducing hip and knee flexion contractures in a child with MMC? 2) Does a home standing program result in a change in the quality of functional movement? A Physical therapist, PT, will administer the Peds NRS and goniometric measurements prior to the start of the study and at the end of the study. The PT will also provide the parent instruction on the standing home program with weekly check-ins to ensure the parent and child are able to follow the home program. The home standing program will last 8 weeks. The parent will keep a written log of stander use. The Peds NRS scores and goniometric measurements will be compared pre and post intervention. The expected outcome is that the Peds NRS scores and hip and knee extension range of motion measurements will improve.

NCT ID: NCT05251337 Completed - Anxiety Clinical Trials

Use of Aromatherapy to Reduce Symptom Burden

Start date: March 7, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effect of inhaled aromatherapy on symptoms of nausea/vomiting and anxiety in patients who have received a stem cell transplant. Aromatherapy involves essential oils from aromatic plants that can be absorbed into the body in different ways. Our study will be using inhaled aromatherapy, which has been found helpful for symptoms such as nausea/vomiting and anxiety.

NCT ID: NCT05251311 Completed - Clinical trials for Social Determinants of Health

A Mixed-Method Evaluation of the Impact of Social Risk Screening on Uptake of Social Assistance

Start date: April 19, 2022
Phase: N/A
Study type: Interventional

Children are disproportionately affected by the rise in poverty rates in the United States. Economic hardships can compromise child development, overall health, and the ability to succeed in school and in life. The current economic recession and racial disparities underscored by COVID19 have magnified this impact on children and hastened the already rapid growth of screening protocols for social risk factors- such as food and housing insecurity, financial strain, and unsafe environments-within pediatric health care. However, it remains unclear what effect standardized screening has on family perception of and engagement with resources. Current implementation momentum for screening protocols is outpacing research, and is raising concern among patient advocates for unintended harm-alienating families for fear of stigma or worse, and overpromising services that may not exist. Through a rigorous mixed-method approach, the proposed study will explore the impact of screening on acceptance, perception, and engagement with social resources among families with children. Furthermore, by leveraging the new technology of resource mapping as the method of resource referral, this study will provide insight regarding its effectiveness as a social needs assistance strategy. The knowledge gained will provide guidance for policymakers and other healthcare systems on how to integrate social risk interventions into healthcare delivery in order to maximize the benefit to children and families.

NCT ID: NCT05251116 Completed - Diabete Mellitus Clinical Trials

Study of an Interstitial Fluid Glucose Sensor

Start date: December 11, 2021
Phase: N/A
Study type: Interventional

To characterize the System performance with respect to Yellow Springs Instrument (YSI) reference venous plasma measurements. Safety of the investigational device will be characterized by Adverse Device Effects and Serious Adverse Device Effects experienced by study participants.

NCT ID: NCT05251064 Completed - Incision, Surgical Clinical Trials

Orthopaedic Surgical Wound Closure Comparison Study

Start date: April 23, 2019
Phase: N/A
Study type: Interventional

This study is trying to find out if there is one method of surgical incision closure is better than another. The three different wound closure methods in this study are currently used in standard of care. The three methods being compared are standard stitches and the wound closure devices, Clozex, and Zipline. All of these methods are approved by the FDA.

NCT ID: NCT05250830 Completed - Post-cesarean Pain Clinical Trials

TrueRelief Efficacy for Post-cesarean Pain (ELECTRON)

ELECTRON
Start date: April 18, 2022
Phase: N/A
Study type: Interventional

This is a randomized trial of 134 individualized post-cesarean delivery who will be randomized to twice daily use of non-invasive bioelectronic treatment with TrueRelief device or identical appearing sham device for post-cesarean pain management.